Teva has announced that its epilepsy medicine Gabitril will be out of stock in the UK until the end of October 2019 as part of a “Europe-wide issue”.
All strengths of the epilepsy medicine Gabitril (tiagabine; Teva) will be out of stock in the UK until the end of October 2019, the drug’s manufacturer has said.
In a statement by the Epilepsy Society, a UK charity for patients with epilepsy, published on 20 August 2019, Teva said it had extended its return to market date from 30 September 2019 to “the end of October [2019]” as a result of issues in the manufacturing process that it said are out of its control.
Teva’s statement added that the 10mg Gabitril tablets “may experience further disruption in supply in early 2020”.